title: 2-Chlorodeoxyadenosine (2-CdA) in chronic lymphocytic leukemia refractory to fludarabine?
authors.forename: M
authors.initials: M
authors.lastname: Schirmer
authors.forename: G
authors.initials: G
authors.lastname: Michlmayr
authors.forename: F
authors.initials: F
authors.lastname: Geisen
authors.forename: G
authors.initials: G
authors.lastname: Konwalinka
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017338:Cladribine / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014740:Vidarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D017338:Cladribine; D014740:Vidarabine; C024352:fludarabine